Denali Therapeutics (DNLI) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.8
-0.76
-0.71
-0.67

Details

Expected EPS
-0.747651
Actual EPS
-0.74
Surprise EPS
0.01
Surprise Percent
+1.02%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.74 per share for Q4 2025.

0 Comments

Share your thoughts